ArticleJTCVS open2025
A single-institution outcome of bronchial valve placement for persistent air leak.
Article in JTCVS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interventional techniques and strategies for postoperative bronchopleural fistula treatment: a narrative review.Journal of thoracic disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Persistent pulmonary air leak happens in a minority of patients with various thoracic pathologies. Spiration (Olympus America Inc.) bronchial valves (BVs) are approved by the Food and Drug Administration under Humanitarian Use Device status to treat persistent air leak after lung resection. We evaluate our experience with use of BVs for air leak resolution attributable to multiple etiologies. Methods: A retrospective review of the use of BVs for persistent air leak at a single institution from 2013 to 2024 was performed. Patient demographics and outcomes were tabulated, and mean, median, and standard deviation were calculated. Results: A total of 67 unique cases of BV placement for persistent air leak after lung resection (n = 49), iatrogenic or spontaneous pneumothorax, pleural malignancy, bronchopleural fistula or exploratory thoracotomy (n = 18) were analyzed. Air leak resolution was at least 95% across all categories, except for the spontaneous pneumothorax cohort (80%). Only 7% of all patients underwent post-BV pleurodesis. Rate of BV removal for lung resection patients was 86% and 72% for other etiologies. 61% of patients were discharged safely with a chest tube. Ninety-day all-cause mortality rate was 9%. Conclusions: BV placement is an endoscopic and well-tolerated method that facilitates discharge with chest tube and resolution of air leak for multiple different etiologies, especially after lung resection to which we proposed an algorithm for persistent air leak management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.